Cart (0 Items)
Your cart is currently empty.
View ProductsRalpancizumab Biosimilar – Anti-PCSK9, NARC1, PC9 mAb – Research Grade
| Size | 100ug, 1MG |
|---|---|
| Isotype | IgG2, kappa |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Ralpancizumab Biosimilar - Anti-PCSK9, NARC1, PC9 mAb - Research Grade |
|---|---|
| Source | CAS 1407495-04-8 |
| Species | Humanized |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Ralpancizumab,PF-05335810,RN317,PCSK9, NARC1, PC9,anti-PCSK9, NARC1, PC9 |
| Reference | PX-TA1340 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG2-kappa |
| Clonality | Monoclonal Antibody |
Description of Ralpancizumab Biosimilar - Anti-PCSK9, NARC1, PC9 mAb - Research Grade
General information on Anti-PCSK9/NARC1/ PC9[Homo sapiens] (Ralpancizumab) Monoclonal Antibody
Ralpancizumab has been investigated for the treatment of Hypercholesterolemia.
Related products
Antigen
Human PCSK9 recombinant protein
PX-P5124 131$
Antigen
PCSK9, C-His, recombinant protein
PX-P5877 500$
Isotype Control
Human IgG2 Isotype Control antibody (HyHEL-10)
PTX17900 214$Contact us
Send us a message from the form below
Reviews
There are no reviews yet.